Skip to main content
PSNY
NASDAQ Manufacturing

Shareholders Approve Authority for Highly Dilutive Share Issuance

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
9
Price
$17.43
Mkt Cap
$2.764B
52W Low
$11.75
52W High
$42.6
Market data snapshot near publication time

Summary

Polestar shareholders approved the authority to issue new shares and waive pre-emption rights, paving the way for a potentially highly dilutive capital raise amidst financial distress and a recent U.S. sales ban.


Key Events

  • Highly Dilutive Share Issuance Authority Approved

    Shareholders approved the authority to issue new ordinary shares and to disapply pre-emption rights. This grants the company the ability to issue shares that could more than double the current outstanding share count, as previously indicated by the company.

  • Auditor Change Confirmed

    Shareholders approved the appointment of PricewaterhouseCoopers LLP and Öhrlings PricewaterhouseCoopers AB as the new independent external auditor, replacing Deloitte AB.

  • Context of Financial Distress and US Sales Ban

    This approval comes after the company disclosed a 'going concern' warning in its annual report, reported significantly widened losses in Q1 2026, and was recently denied authorization to sell new models in the U.S. from 2027.


Analysis

Shareholders have approved the company's request for authority to issue new ordinary shares and to disapply pre-emption rights. This follows a prior announcement that the company was seeking approval to potentially more than double its current share capital. This approval grants Polestar the ability to raise substantial capital, which is critical given its recent 'going concern' warning, widening losses, and the recent ban on selling new models in the U.S. from 2027. While it provides a pathway for funding, it also signals a high likelihood of significant dilution for existing shareholders.

At the time of this filing, PSNY was trading at $17.43 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $2.8B. The 52-week trading range was $11.75 to $42.60. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PSNY - Latest Insights

PSNY
Jun 26, 2026, 4:21 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $17.43
Real-time Price: $17.43 info
Change: $0 (0%) info
Market Cap: $2.764B info
PSNY
Jun 25, 2026, 11:19 AM EDT
Source: Dow Jones Newswires
Importance Score:
10
Price at Filing: $18.75
Real-time Price: $17.43 info
Change: -$1.32 (-7%) info
Market Cap: $2.764B info
PSNY
Jun 25, 2026, 9:00 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $19.99
Real-time Price: $17.43 info
Change: -$2.56 (-13%) info
Market Cap: $2.764B info
PSNY
Jun 25, 2026, 9:00 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $20.00
Real-time Price: $17.43 info
Change: -$2.57 (-13%) info
Market Cap: $2.764B info
PSNY
Jun 03, 2026, 9:15 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $19.42
Real-time Price: $17.43 info
Change: -$1.99 (-10%) info
Market Cap: $2.764B info
PSNY
Jun 02, 2026, 7:22 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $19.37
Real-time Price: $17.43 info
Change: -$1.94 (-10%) info
Market Cap: $2.764B info
PSNY
May 19, 2026, 7:30 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $20.58
Real-time Price: $17.43 info
Change: -$3.15 (-15%) info
Market Cap: $2.764B info
PSNY
May 07, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $18.06
Real-time Price: $17.43 info
Change: -$0.630 (-3%) info
Market Cap: $2.764B info
PSNY
May 07, 2026, 7:00 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $18.06
Real-time Price: $17.43 info
Change: -$0.630 (-3%) info
Market Cap: $2.764B info
PSNY
Apr 17, 2026, 4:21 PM EDT
Filing Type: 20-F
Importance Score:
10
Price at Filing: $18.06
Real-time Price: $17.43 info
Change: -$0.630 (-3%) info
Market Cap: $2.764B info